AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Bioreactor System For The Large Scale Production Of Pluripotent Stem Cells And Their Derivatives. (Hadasit)

Summary

There is a great need for the development of a robust large scale cell production to facilitate the development of novel hPSC based therapeutics. The exploitation of Human pluripotent stem cells (hPSCs) for regenerative medicine and stem cell based R&D applications will depend on the availability of a large scale production or “banking” platform for hPSCs and their differentiated progeny. The lack of hPSC large scale production platforms presents a serious challenge for successful translation of novel cell based therapies into clinical settings. There is a great need for the development of a robust large scale cell production to facilitate the development of novel hPSC based therapeutics. We are currently developing a bioreactor system for large scale production of hPSCs. Our investigators are aiming at providing a proof of concept for the feasibility of an automated dynamic bioreactor culture system.

Technology Benefits

Currently, hPSCs are propagated as monolayer colonies within highly variable and labor-intensive culture systems, which do not allow large-scale production of standardized homogenous hPSCs.

Technology Application

Novel hPSC based therapeutics.

ID No.

8-2010-83

Country/Region

Israel

For more information, please click Here